Boston Scientific Logo

   
 

TAXUS™ Stent in Diabetics
View evidence which shows the benefits of selecting TAXUS™ Stent in this difficult to treat group of patients
News Releases
 
 
Other Resources
Boston Scientific is not responsible for the content of these sites.

* Vs BMS: TAXUS 4 –year meta-analysis (All Diabetics) presented by Dr. Stone, TCT 2006. TAXUS Stent meta-analysis (all diabetics): TAXUS II1 (4 yr) , IV2 (4 yr), V3 (2yr), VI4 (3 yr) (N=3445). 1. Colombo et al. Circulation. 2003;108:788; 2. Stone et al. N Engl Med. 2004;350:221; 3. Stone et al. JAMA. 2005;294:1215; 4. Dawkins et al. Circulation. 2005;112:3306. Vs Cypher™ Stent: TC WYRE registry data presented by Dr. Kandzari and Dr. O’Neill at TCT 2006. Kaiser Permanente registry data presented by Dr. Brar at TCT 2006. Prairie Heart Institute registry data presented by Dr. Mishkel et al. TCT 2006. T-Search/Research registry presented by Dr. Daemen at AHA 2006. Cypher is a registered trademark of J&J/Cordis Corp.

This section is reserved to Medical Professionals. Not all products are available in all geographies. Please check availability of the product with your local sales representative or your local customer service.